BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30365601)

  • 1. Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-Analysis.
    Radaelli G; Sausen G; Cesa CC; Santos FS; Portal VL; Neyeloff JL; Pellanda LC
    Arq Bras Cardiol; 2018 Dec; 111(6):810-821. PubMed ID: 30365601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins for children with familial hypercholesterolemia.
    Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E; Ramaswami U
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD006401. PubMed ID: 28685504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins for children with familial hypercholesterolemia.
    Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006401. PubMed ID: 25054950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins for children with familial hypercholesterolemia.
    Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E; Ramaswami U
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
    Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis to evaluate the efficacy of statins in children with familial hypercholesterolemia.
    Shafiq N; Bhasin B; Pattanaik S; Pandhi P; Venkateshan SP; Singh M; Malhotra S
    Int J Clin Pharmacol Ther; 2007 Oct; 45(10):548-55. PubMed ID: 17966840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.
    Miltiadous G; Saougos V; Cariolou M; Elisaf MS
    Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
    McCullough PA; Ballantyne CM; Sanganalmath SK; Langslet G; Baum SJ; Shah PK; Koren A; Mandel J; Davidson MH
    Am J Cardiol; 2018 Apr; 121(8):940-948. PubMed ID: 29472008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins for children with familial hypercholesterolemia.
    Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Strandberg T; Tonstad S; Gylling H
    Cochrane Database Syst Rev; 2010 Jul; (7):CD006401. PubMed ID: 20614444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial.
    Raal F; Scott R; Somaratne R; Bridges I; Li G; Wasserman SM; Stein EA
    Circulation; 2012 Nov; 126(20):2408-17. PubMed ID: 23129602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment.
    Holven KB; Narverud I; Lindvig HW; Halvorsen B; Langslet G; Nenseter MS; Ulven SM; Ose L; Aukrust P; Retterstøl K
    Atherosclerosis; 2014 Apr; 233(2):561-567. PubMed ID: 24530965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia.
    Avis HJ; Vissers MN; Stein EA; Wijburg FA; Trip MD; Kastelein JJ; Hutten BA
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1803-10. PubMed ID: 17569881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy.
    Mikhailidis DP; Sibbring GC; Ballantyne CM; Davies GM; Catapano AL
    Curr Med Res Opin; 2007 Aug; 23(8):2009-26. PubMed ID: 17659159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher.
    Ginsberg HN; Rader DJ; Raal FJ; Guyton JR; Baccara-Dinet MT; Lorenzato C; Pordy R; Stroes E
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):473-483. PubMed ID: 27618825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis.
    Ambegaonkar BM; Tipping D; Polis AB; Tomassini JE; Tershakovec AM
    Atherosclerosis; 2014 Dec; 237(2):829-37. PubMed ID: 25463129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia.
    Ravnskov U; de Lorgeril M; Kendrick M; Diamond DM
    Med Hypotheses; 2018 Dec; 121():60-63. PubMed ID: 30396495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lipid-lowering treatment on natural history of heterozygous familial hypercholesterolemia in past three decades.
    Elis A; Zhou R; Stein EA
    Am J Cardiol; 2011 Jul; 108(2):223-6. PubMed ID: 21545982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations.
    Stein EA; Dann EJ; Wiegman A; Skovby F; Gaudet D; Sokal E; Charng MJ; Mohamed M; Luirink I; Raichlen JS; Sundén M; Carlsson SC; Raal FJ; Kastelein JJP
    J Am Coll Cardiol; 2017 Aug; 70(9):1162-1170. PubMed ID: 28838366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.
    Lambert M; Lupien PJ; Gagné C; Lévy E; Blaichman S; Langlois S; Hayden M; Rose V; Clarke JT; Wolfe BM; Clarson C; Parsons H; Stephure DK; Potvin D; Lambert J
    Pediatrics; 1996 May; 97(5):619-28. PubMed ID: 8628597
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.